for the 2003 strain. We found that the spacer sequence remained stable over the ≈10-year period. This finding suggests a high intrastrain genetic stability and highlights the value of the typing system, which is stable. Thus, a change in genotype in a patient with Whipple disease must be interpreted as an infection with a different strain and cannot be attributed to mutation of the original strain.
To (3, 6) , but it has not been described in Germany or Austria ( Figure) .
Genotype 1 is found throughout central Europe and is the second most common genotype (15.2% of all samples) ( Figure) . Predominance of this genotype in Germany is high (46.2%, n = 13) and Austria (80%, n = 5). Infection with this genotype seems to be endemic in the population of the area, although no outbreaks have been reported.
Of 191samples, a total of 55 (28.8%) showed a unique genotype consistent with the high genetic variability in T. whipplei specimens. Phylogenetic analysis and clustering of these singletons showed no correlation between clusters and geographic origin of samples.
Of the 191 samples, a total of 66 (34.6%) were from Marseille and represented 40 different genotypes. This finding underscores the broad heterogeneity in T. whipplei. Twelve (18.5%) of the 66 tested samples were genotype 3, which might be linked to the local outbreak among homeless persons mentioned above. Genotype 1, which is endemic to France, was found in only 2 (3.1%) persons in Marseille. The fact that Marseille is a metropolitan area with a high migration rate could play a role in the vast diversity of T. whipplei genotypes found there
Questions regarding the epidemiologic character of Whipple disease remain unanswered, such as why the bacterium is highly prevalent but the disease is not. Persons with the putative immunological defect probably responsible for classic Whipple disease (1) have the highest bacterial load in their stools. But these persons are unlikely to come into direct contact with one another. Thus, propagation of this bacterium on a large scale might be relatively limited, which could explain the high genetic diversity in the bacterial specimens assessed so far.
Two predominant genotypes seem to break out of this pattern: genotypes 1 and 3. Genotype 3 could be considered a genotype that causes small epidemics, whereas genotype 1 could be considered a genotype endemic to central Europe. Reasons for the success of these 2 genotypes remain unknown, but improvement of genotyping methods could provide the answers. To the Editor: Yersinia pestis causes plague, which primarily affects rodents, but is an invasive and virulent pathogen among humans. Y. pestis infection is endemic in small rodent populations in different parts of the world, and the bacterium is considered a potential bioweapon because it can be easily isolated, produced, dried, and dispersed as an aerosol. Antimicrobial drug treatment can be lifesaving during the early stages of illness; hence, rapid and sensitive methods for Y. pestis detection in environmental and clinical samples are required. Multiple PCR assays for Y. pestis detection that primarily detect markers located on plasmids have been developed (1-6). The plasminogen activator/coagulase (pla) gene, located on plasmid pPCP1, is incorporated into most Y. pestis PCR assays, and in several studies it was the prime or sole marker (1, 2, 5, (7) (8) (9) . Reasons for including pla in these assays are its occurrence in multiple copies, its absence from closely related Yersinia species, and its role in Y. pestis virulence (1, 4, 5) .
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